Jove
Visualize
Contact Us

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

245
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
245
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

2.2K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.2K
Immunogold Electron Microscopy01:20

Immunogold Electron Microscopy

5.7K
Immunoelectron microscopy utilizes immunogold labeling of endogenous proteins with specific antibodies to detect and localize these proteins in cells and tissues. The procedure provides insights into the distribution and quantification of protein under different stimulation conditions offering clues about their functions. Conjugating highly electron-dense gold particles with primary or secondary antibodies allow antigen detection on and within cells, with high resolution and specificity.
5.7K
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

824
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
824
Hepatic Drug Excretion: Enterohepatic Cycling01:17

Hepatic Drug Excretion: Enterohepatic Cycling

3.1K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
3.1K
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

691
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
691

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Prescription for Improving Oklahoma's Health.

Journal - Oklahoma Dental Association·2015
Same author

Development of protective immunity to Salmonella, a mucosal pathogen with a systemic agenda.

Mucosal immunology·2011
Same author

Parenteral methotrexate should be given before biological therapy.

Rheumatology (Oxford, England)·2004
Same author

Misleading results from immunoassays of serum free thyroxine in the presence of rheumatoid factor.

Clinical chemistry·1997
Same author

The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women.

Arthritis and rheumatism·1993
Same author

Indomethacin treatment in newborn canine endotoxic shock.

Japanese heart journal·1991
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 9, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

3.5K

Cholestatic hepatitis induced by gold.

A J Griffin

    Rheumatology and Rehabilitation
    |August 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Gold therapy for rheumatoid arthritis can rarely cause liver damage. A patient experienced acute intrahepatic cholestasis after sodium aurothiomalate treatment, highlighting this uncommon but serious side effect.

    More Related Videos

    The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
    07:27

    The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury

    Published on: October 21, 2017

    12.5K
    The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
    09:03

    The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

    Published on: February 3, 2012

    20.0K

    Related Experiment Videos

    Last Updated: Mar 9, 2026

    Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
    11:36

    Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

    Published on: May 29, 2020

    3.5K
    The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
    07:27

    The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury

    Published on: October 21, 2017

    12.5K
    The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
    09:03

    The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

    Published on: February 3, 2012

    20.0K

    Area of Science:

    • Hepatology
    • Rheumatology
    • Clinical Pharmacology

    Background:

    • Rheumatoid arthritis (RA) management often involves disease-modifying anti-rheumatic drugs (DMARDs).
    • Hepatotoxicity is a known potential adverse effect of various anti-inflammatory agents used in RA treatment.
    • Gold compounds were historically significant DMARDs, but their use has declined.

    Observation:

    • A patient diagnosed with rheumatoid arthritis presented with acute intrahepatic cholestasis.
    • The cholestatic event occurred subsequent to the administration of 100 mg of sodium aurothiomalate.
    • This adverse event suggests a potential link between gold therapy and liver injury.

    Findings:

    • Acute intrahepatic cholestasis is a rare complication associated with gold therapy for rheumatoid arthritis.
    • The case underscores the importance of monitoring liver function in patients receiving gold salts.
    • Review of existing literature confirms the rarity of hepatotoxicity from gold compounds in current RA treatment.

    Implications:

    • Clinicians should remain vigilant for rare hepatotoxic reactions even with less commonly used RA medications.
    • This case highlights the need for continued pharmacovigilance for established and historical drug therapies.
    • Understanding rare adverse drug reactions is crucial for patient safety in rheumatology practice.